Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,415.00p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,618.00p
  • 52 Week Low: 855.60p
  • Currency: UK Pounds
  • Shares Issued: 241.42m
  • Volume: 31,804
  • Market Cap: 3,416.06m
  • RiskGrade: 176
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 1,365.00 298.00 139.10¢ 11.3 0.1 +126% 20.00¢ 1.3%
31-Dec-14 1,489.00 362.00 151.00¢ 17.2 1.9 +9% 22.00¢ 0.8%
31-Dec-15 1,440.00 318.00 143.70¢ 21.0 n/a -5% 32.00¢ 1.1%
31-Dec-16 1,950.00 210.00 118.50¢ 21.0 n/a -18% 33.00¢ 1.3%
31-Dec-17 1,936.00 (738.00) 105.00¢ 14.2 n/a -11% 34.00¢ 2.3%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 1,390.20 186.70 66.75p 21.1 n/a -16% 22.77p 1.6%
31-Dec-19 1,426.86 211.35 74.21p 19.0 1.7 +11% 24.29p 1.7%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 14.29 14.29 18.52 0.96

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HIK Market Data

Currency UK Pounds
Share Price 1,415.00p
Change Today 7.50p
% Change 0.53 %
52 Week High 1,618.00p
52 Week Low 855.60p
Volume 31,804
Shares Issued 241.42m
Market Cap 3,416.06m
Beta 0.00
RiskGrade 176

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.93% below the market average32.93% below the market average32.93% below the market average32.93% below the market average32.93% below the market average
80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average
Price Trend
26% below the market average26% below the market average26% below the market average26% below the market average26% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Income
53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
77.15% below the market average77.15% below the market average77.15% below the market average77.15% below the market average77.15% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 6
Sell 1
Strong Sell 2
Total 13
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 05-Apr-18 24-Aug-17
Paid 24-May-18 22-Sep-17
Amount 23.00¢ 11.00¢

Trades for 21-Jun-2018

Time Volume / Share Price
09:08 100 @ 1,415.00p
09:08 200 @ 1,415.00p
09:08 12 @ 1,414.00p
09:08 110 @ 1,414.00p
09:08 141 @ 1,415.00p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page